SB Drug Discovery

SB Drug Discovery (part of Sygnature Discovery) is an industry leader in specialist contract research, providing critical data for novel drug development through cell line generation, assay development and compound screening services. With a global reputation for outstanding customer service, our clients know their research is in the best hands. Using the latest technologies, our expert teams deliver fast, reliable and robust data customized to meet our clients requirements and are on-hand to discuss options at every stage. Together, we are driving the discovery of tomorrows novel therapeutics - today

Ion channel screening,pde screening,nuclear receptor screening,inflammatory assays,gpcr assays,cell line generation,high throughput screening,transporter assays,electrophysiology,and selectivty assays

Sb drug discovery operates in the Biotechnology research industry.

Sb drug discovery's revenue is 11m - 100m

Sb drug discovery has 11 - 50 employees.